<?xml version="1.0" ?>
<document id="29309627">
  <sentence id="29309627.s0" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor regulation of transcription by RNA polymerase II that interacts with NONO/p54NRB, a survival factor.">
    <entity charOffset="48-54" id="29309627.s0.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="207-255" id="29309627.s0.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="29309627.s0.e0" e2="29309627.s0.e1" id="29309627.s0.p0" relation="true"/>
  </sentence>
  <sentence id="29309627.s1" text="Also, two somatic heterozygous activation of innate immune response mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine tumor).">
    <entity charOffset="31-67" id="29309627.s1.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="110-116" id="29309627.s1.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="29309627.s1.e0" e2="29309627.s1.e1" id="29309627.s1.p0" relation="true"/>
  </sentence>
  <sentence id="29309627.s2" text="Our studies implicate therapeutic strategies for either reducing β-cell proliferation in insulinomas or alleviating normal β-cell deficiency in diabetes through the modulation of regulation of transcription by RNA polymerase II phosphorylation">
    <entity charOffset="89-100" id="29309627.s2.e0" ontology_id="HP_0012197" text="insulinomas" type="HP"/>
    <entity charOffset="179-227" id="29309627.s2.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="29309627.s2.e0" e2="29309627.s2.e1" id="29309627.s2.p0" relation="true"/>
  </sentence>
</document>
